Listed

Silence Therapeutics plc

SLNNasdaqCIK 1479615Healthcare

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$13.9m, Q2 FY2026
Net income−$12.3m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m15.7Revenue, period not labelled, three months to 2024-03-31$15.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure0.8Revenue, period not labelled, three months to 2024-06-30$756.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure1.5Revenue, period not labelled, three months to 2024-09-30$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure25.3Revenue, Q4 FY2024, three months to 2024-12-31$25.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.1Revenue, Q1 FY2025, three months to 2025-03-31$142.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.2Revenue, Q2 FY2025, three months to 2025-06-30$224.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure0.2Revenue, Q3 FY2025, three months to 2025-09-30$159.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$34.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.4Revenue, Q1 FY2026, three months to 2026-03-31$422.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Cost of revenue$m2.8Cost of revenue, period not labelled, three months to 2024-03-31$2.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure3.3Cost of revenue, period not labelled, three months to 2024-06-30$3.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure3.6Cost of revenue, period not labelled, three months to 2024-09-30$3.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure2.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.1Cost of revenue, Q1 FY2025, three months to 2025-03-31$54.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$85.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure0.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$64.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$12.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$11.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Gross profit$m12.9Gross profit, period not labelled, three months to 2024-03-31$12.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure(2.6)Gross profit, period not labelled, three months to 2024-06-30−$2.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure(2.1)Gross profit, period not labelled, three months to 2024-09-30−$2.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure23.3Gross profit, Q4 FY2024, three months to 2024-12-31$23.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.1Gross profit, Q1 FY2025, three months to 2025-03-31$88.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.1Gross profit, Q2 FY2025, three months to 2025-06-30$139.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure0.1Gross profit, Q3 FY2025, three months to 2025-09-30$95.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure0.0Gross profit, Q4 FY2025, three months to 2025-12-31$22.0k. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.4Gross profit, Q1 FY2026, three months to 2026-03-31$411.0k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Gross profit, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Research and development$m11.8Research and development, period not labelled, three months to 2024-03-31$11.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure13.8Research and development, period not labelled, three months to 2024-06-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure20.2Research and development, period not labelled, three months to 2024-09-30$20.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure22.1Research and development, Q4 FY2024, three months to 2024-12-31$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure20.8Research and development, Q1 FY2025, three months to 2025-03-31$20.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure17.6Research and development, Q2 FY2025, three months to 2025-06-30$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure20.5Research and development, Q3 FY2025, three months to 2025-09-30$20.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure8.7Research and development, Q4 FY2025, three months to 2025-12-31$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure9.1Research and development, Q1 FY2026, three months to 2026-03-31$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure9.1Research and development, Q2 FY2026, three months to 2026-06-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Operating income$m(5.6)Operating income, period not labelled, three months to 2024-03-31−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure(23.4)Operating income, period not labelled, three months to 2024-06-30−$23.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure(30.0)Operating income, period not labelled, three months to 2024-09-30−$30.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure(4.4)Operating income, Q4 FY2024, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure(28.4)Operating income, Q1 FY2025, three months to 2025-03-31−$28.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(24.0)Operating income, Q2 FY2025, three months to 2025-06-30−$24.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure(26.2)Operating income, Q3 FY2025, three months to 2025-09-30−$26.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure(12.5)Operating income, Q4 FY2025, three months to 2025-12-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Operating income, Q1 FY2026, three months to 2026-03-31−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(13.9)Operating income, Q2 FY2026, three months to 2026-06-30−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Income tax$m0.2Income tax, period not labelled, three months to 2024-03-31$244.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure0.2Income tax, period not labelled, three months to 2024-06-30$228.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure0.0Income tax, period not labelled, three months to 2024-09-30$49.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure0.3Income tax, Q4 FY2024, three months to 2024-12-31$324.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Net income$m(2.3)Net income, period not labelled, three months to 2024-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure(19.8)Net income, period not labelled, three months to 2024-06-30−$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure(35.5)Net income, period not labelled, three months to 2024-09-30−$35.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure12.3Net income, Q4 FY2024, three months to 2024-12-31$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure(28.5)Net income, Q1 FY2025, three months to 2025-03-31−$28.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure(27.4)Net income, Q2 FY2025, three months to 2025-06-30−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure(21.0)Net income, Q3 FY2025, three months to 2025-09-30−$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure(11.8)Net income, Q4 FY2025, three months to 2025-12-31−$11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure(15.0)Net income, Q1 FY2026, three months to 2026-03-31−$15.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure(12.3)Net income, Q2 FY2026, three months to 2026-06-30−$12.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Diluted EPS$ per share(0.02)Diluted EPS, period not labelled, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure(0.14)Diluted EPS, period not labelled, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure(0.25)Diluted EPS, period not labelled, three months to 2024-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(0.19)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure(0.15)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figurenot reported(0.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(0.09)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Basic EPS$ per share(0.02)Basic EPS, period not labelled, three months to 2024-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure(0.14)Basic EPS, period not labelled, three months to 2024-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure(0.25)Basic EPS, period not labelled, three months to 2024-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figurenot reported(0.20)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(0.19)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure(0.15)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figurenot reported(0.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(0.09)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure

Balance sheet

Cash and equivalents$72.1m, Q2 FY2026
Shareholders' equity$38.5m, Q2 FY2026
Line itemUnitFY20222022-12-31FY20232023-12-31period not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported68.8Cash and equivalents, FY2023, at 2023-12-31$68.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-029129.Report this figurenot reportednot reportednot reported121Cash and equivalents, FY2024, at 2024-12-31$121.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-092591.Report this figure64.9Cash and equivalents, Q1 FY2025, at 2025-03-31$64.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure41.7Cash and equivalents, Q2 FY2025, at 2025-06-30$41.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure82.0Cash and equivalents, Q3 FY2025, at 2025-09-30$82.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure11.3Cash and equivalents, FY2025, at 2025-12-31$11.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure5.7Cash and equivalents, Q1 FY2026, at 2026-03-31$5.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure72.1Cash and equivalents, Q2 FY2026, at 2026-06-30$72.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Current assets$m96.7Current assets, FY2022, at 2022-12-31GBP 96.7m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-03-13, accession 0000950170-24-030519.Report this figure103Current assets, FY2023, at 2023-12-31$103.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029129.Report this figurenot reportednot reportednot reported187Current assets, FY2024, at 2024-12-31$187.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092591.Report this figure170Current assets, Q1 FY2025, at 2025-03-31$169.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure149Current assets, Q2 FY2025, at 2025-06-30$148.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure134Current assets, Q3 FY2025, at 2025-09-30$133.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure119Current assets, FY2025, at 2025-12-31$118.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure103Current assets, Q1 FY2026, at 2026-03-31$102.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure94.3Current assets, Q2 FY2026, at 2026-06-30$94.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Total assets$mnot reported119Total assets, FY2023, at 2023-12-31$119.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-029129.Report this figurenot reportednot reportednot reported203Total assets, FY2024, at 2024-12-31$202.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-092591.Report this figure185Total assets, Q1 FY2025, at 2025-03-31$185.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure165Total assets, Q2 FY2025, at 2025-06-30$165.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure147Total assets, Q3 FY2025, at 2025-09-30$146.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure131Total assets, FY2025, at 2025-12-31$131.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure115Total assets, Q1 FY2026, at 2026-03-31$115.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure106Total assets, Q2 FY2026, at 2026-06-30$106.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Current liabilities$m21.9Current liabilities, FY2022, at 2022-12-31GBP 21.9m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-03-13, accession 0000950170-24-030519.Report this figure22.3Current liabilities, FY2023, at 2023-12-31$22.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-029129.Report this figurenot reportednot reportednot reported16.8Current liabilities, FY2024, at 2024-12-31$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092591.Report this figure19.3Current liabilities, Q1 FY2025, at 2025-03-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure14.8Current liabilities, Q2 FY2025, at 2025-06-30$14.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure17.4Current liabilities, Q3 FY2025, at 2025-09-30$17.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure13.6Current liabilities, FY2025, at 2025-12-31$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure10.5Current liabilities, Q1 FY2026, at 2026-03-31$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure12.7Current liabilities, Q2 FY2026, at 2026-06-30$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Total liabilities$mnot reported97.5Total liabilities, FY2023, at 2023-12-31$97.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-029129.Report this figurenot reportednot reportednot reported68.6Total liabilities, FY2024, at 2024-12-31$68.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-092591.Report this figure72.6Total liabilities, Q1 FY2025, at 2025-03-31$72.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure71.1Total liabilities, Q2 FY2025, at 2025-06-30$71.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure72.7Total liabilities, Q3 FY2025, at 2025-09-30$72.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure69.1Total liabilities, FY2025, at 2025-12-31$69.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure65.7Total liabilities, Q1 FY2026, at 2026-03-31$65.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure67.9Total liabilities, Q2 FY2026, at 2026-06-30$67.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure
Shareholders' equity$m27.2Shareholders' equity, FY2022, at 2022-12-31$27.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-27, accession 0000950170-25-029129.Report this figure22.0Shareholders' equity, FY2023, at 2023-12-31$22.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-092591.Report this figure157Shareholders' equity, period not labelled, at 2024-03-31$156.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure143Shareholders' equity, period not labelled, at 2024-06-30$142.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure127Shareholders' equity, period not labelled, at 2024-09-30$126.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure134Shareholders' equity, FY2024, at 2024-12-31$134.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure113Shareholders' equity, Q1 FY2025, at 2025-03-31$112.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure94.2Shareholders' equity, Q2 FY2025, at 2025-06-30$94.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure74.1Shareholders' equity, Q3 FY2025, at 2025-09-30$74.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure62.3Shareholders' equity, FY2025, at 2025-12-31$62.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure49.4Shareholders' equity, Q1 FY2026, at 2026-03-31$49.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure38.5Shareholders' equity, Q2 FY2026, at 2026-06-30$38.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure

Cash flow

Operating cash flow$1.5m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(9.1)Operating cash flow, period not labelled, three months to 2024-03-31−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure(5.4)Operating cash flow, period not labelled, three months to 2024-06-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104593. Derived: 6-month figure less the 3-month figure.Report this figure(25.6)Operating cash flow, period not labelled, three months to 2024-09-30−$25.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268116. Derived: 9-month figure less the 6-month figure.Report this figure(27.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$27.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure(12.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure(21.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-341248. Derived: 6-month figure less the 3-month figure.Report this figure(10.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268116. Derived: 9-month figure less the 6-month figure.Report this figure(17.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure(15.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure1.5Operating cash flow, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-341248. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure0.1Capital expenditure, period not labelled, three months to 2024-06-30$85.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104593. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, period not labelled, three months to 2024-09-30$64.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268116. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$62.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$4.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-341248. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268116. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092591. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-341248. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)141.71m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares132Diluted shares (weighted), period not labelled, three months to 2024-03-31131,881,115 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066439.Report this figure140Diluted shares (weighted), period not labelled, three months to 2024-06-30140,208,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-104593.Report this figure141Diluted shares (weighted), period not labelled, three months to 2024-09-30141,198,163 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure142Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31141,678,734 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure142Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30141,696,047 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure142Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30141,701,848 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268116.Report this figure142Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31141,702,578 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210446.Report this figure142Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30141,709,762 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure

Shares outstanding: 141.74mShares outstanding, period not labelled, at 2026-07-31141,740,037 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001193125-26-341248.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.